Search Results 521-530 of 15548 for cannabis

  1. Mayo Clinic Olmsted Study of Aging (MCSA)

    This study is being done to learn more about normal memory and aging, mild memory and thinking problems, Alzheimer's disease and other forms of dementia. This ...

  2. Discovery's Edge: Plugging into drug discovery - Mayo Clinic News Network

    And Dr. Bram knew that pharmaceutical companies wouldn't likely be interested in the finding about the cyclophilin B protein because the market for brain tumor ...

  3. Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery - Mayo Clinic

    Irinotecan may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as cetuximab and bevacizumab, ...

  4. The Olmsted NAFLD Epidemiology Study (TONES) - Mayo Clinic

    Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. It is ...

  5. Narcolepsy - Doctors and departments - Mayo Clinic

    Learn more about this sleep disorder that causes periods of involuntary sleep, sleep paralysis and early rapid eye movement (REM) sleep.

  6. Frequently Asked Questions - Center for Clinical and Translational Science - Center for Clinical and Translational Science (CCaTS)

    View frequently asked questions about Mayo Clinic Center for Clinical and Translational Science (CCaTS) workforce development educational programs.

  7. Intensive tobacco treatment program - Doctors by specialty - Mayo Clinic

    Allied health professionals. Jennifer M. Burden, Ph.D., C.T.T.S.; Barbara Dallavalle, M.A., C.T.T.S.; Sarah E. Huiskes, M.A., L.I.C.S.W., M.S.W ...

  8. Consumer health Integrative medicine - Mayo Clinic

    Meditation. Yoga. Massage. Acupuncture. Use of supplements, such as vitamins, herbs and minerals. Music therapy. Integrative medicine aims to fit each person's ...

  9. Molecular Development Service Line - Mayo Clinic Research Core Facilities

    Mayo Clinic Research Core Facilities: Molecular development cores produce monoclonal and polyclonal antibodies and transgenic and knockout mice.

  10. Transcript of sound bite comments on new class of PCSK9 inhibitor cholesterol lowering medications awaiting FDA approval. Steph

    “So I tell patients it's kind of like putting your garbage out and your garbage can on Wednesday for the garbage man. He or she comes by and takes both the ...